A large population-based study shows a stark reality: colorectal cancer (CRC) risk isn’t just about screening—it’s about completion of the screening pathway.
Among individuals with a positive stool test (FOBT), those who did not undergo follow-up colonoscopy had ~4x higher CRC incidence, while those who completed colonoscopy—especially with negative findings—had lower-than-average cancer risk. This flips the usual narrative: the initial test is only as valuable as the system that ensures follow-through.
What’s particularly notable is the role of quality and system design. In this Swedish program, high colonoscopy completion rates (~87%) and strict quality standards for endoscopists contributed to better outcomes. This suggests that screening effectiveness is less about the modality (stool vs colonoscopy) and more about execution—tracking, navigation, and quality assurance.